SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+29.39%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.42B
AUM Growth
+$1.42B
(+22%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
112
New
24
Increased
30
Reduced
36
Closed
15
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$62.3M |
| 2 |
Maravai LifeSciences
MRVI
|
$27.5M |
| 3 |
Replimune Group
REPL
|
$25.5M |
| 4 |
Tandem Diabetes Care
TNDM
|
$23.8M |
| 5 |
Certara
CERT
|
$20.4M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$51M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
$18.7M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
$18.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$17.7M |
| 5 |
Assembly Biosciences
ASMB
|
$15.1M |
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Industrials | 1.99% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Castle Biosciences
CSTL
$673M
| – | – |
-18,500
| Closed | -$952K |
|
102
Dyne Therapeutics
DYN
$1.92B
| – | – |
-474,301
| Closed | -$9.58M |
|
103
Emergent Biosolutions
EBS
$418M
| – | – |
-79,950
| Closed | -$8.26M |
|
104
Generation Bio
GBIO
$40.3M
| – | – |
-35,000
| Closed | -$1.08M |
|
105
Humana
HUM
$37.5B
| – | – |
-2,666
| Closed | -$1.1M |
|
106
Outset Medical
OM
$245M
| – | – |
-69,773
| Closed | -$3.49M |
|
107
Taysha Gene Therapies
TSHA
$791M
| – | – |
-373,775
| Closed | -$8.37M |
|
|
108
Zentalis Pharmaceuticals
ZNTL
$123M
| – | – |
-556,712
| Closed | -$18.2M |
|
|
GBT
109
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-255,271
| Closed | -$14.1M |
|
|
CHNG
110
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| – | – |
-82,145
| Closed | -$1.19M |
|
|
HMSY
111
DELISTED
HMS Holdings Corp.
HMSY
| – | – |
-782,563
| Closed | -$18.7M |
|
|
IMMU
112
DELISTED
Immunomedics Inc
IMMU
| – | – |
-600,242
| Closed | -$51M |
|